SPPH OTC
Spencer Pharmaceutical Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$0
-100.0% ▼
Operating Income
$863K
-62.2% ▼
Net Income
-$863K
+61.5% ▲
EPS (Diluted)
$-1.00
+66.7% ▲
EBITDA
-$863K
+61.4% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2001 | FY2002 | FY2003 |
|---|---|---|---|
| Revenue | $941K | $3M | $0 |
| YoY Growth | +0.0% | +178.8% | -100.0% |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $941K | $3M | $0 |
| Gross Margin | 100.0% | 100.0% | — |
| R&D Expenses | $1M | $4M | $266K |
| SG&A Expenses | $2M | $912K | $602K |
| Operating Expenses | -$1M | $343K | -$863K |
| Operating Income | $2M | $2M | $863K |
| Operating Margin | 238.4% | 86.9% | — |
| Interest Expense | $0 | $0 | $0 |
| Income Before Tax | -$2M | -$2M | -$863K |
| Tax Expense | $40K | -$26K | $0 |
| Net Income | -$2M | -$2M | -$863K |
| Net Margin | -236.4% | -85.3% | — |
| EPS (Diluted) | $-3.25 | $-3.00 | $-1.00 |
| EBITDA | -$1M | -$2M | -$863K |
| Shares Outstanding | 699018 | 745417 | 782972 |